Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001638599-19-000574
Filing Date
2019-05-31
Accepted
2019-05-31 16:16:44
Documents
1
Period of Report
2019-02-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4a_6128.html 4/A  
1 PRIMARY DOCUMENT doc4a_6128.xml 4/A 47271
  Complete submission text file 0001638599-19-000574.txt   48909
Mailing Address C/O IBIO, INC. 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address
Kay Robert (Reporting) CIK: 0001285612 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35023 | Film No.: 19870657

Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations